Chewy shares have drawn fresh investor attention after the pet retailer's latest results showed revenue above consensus estimates. The stock outperformed its retail peers, with a 30-day return of 20.03%. Longer-term returns remain weak. The shares are down 34.52% year to date, and the one-year total shareholder return is down 37.54%, though the three-year return is a 21.70% gain. The most followed investor narrative puts fair value at $28.64, 23% above the latest close of $21.93. Autoship customer sales reached $2.8 billion in the second quarter of fiscal 2026, or 84.6% of net sales, and are growing faster than overall sales. Valuation is a concern. Chewy trades at a price-to-earnings ratio of 32.2x, against 17.4x for the US specialty retail industry and a fair ratio of 21.1x.

Chewy shares trade at about $21.93, down 71.1% over five years, and some analysts say the price still looks high. At roughly 32.2 times earnings, the pet retailer trades at almost double the Specialty Retail sector average of about 17.0 times and above its peer group's 16.4 times. A fair price-to-earnings measure that factors in margins, scale and risk points to a lower level than today's price. On that metric, the stock screens overvalued. Bulls point to Autoship, the recurring-order programme. Its customer sales reached $2.8 billion in the second quarter of fiscal 2026, or 84.6% of net sales, and are growing faster than overall sales. Bears say softer discretionary spending and slower premiumisation could cap sales per active customer.

Chewy's earnings outlook is weakening even as brokerages stay bullish. Analysts' average recommendation sits between Strong Buy and Buy, but a lower Zacks Rank reflects negative estimate revisions. The company cut its fiscal 2026 net sales expectations because consumer spending cooled. Shoppers trading down on premium treats and toppers remain the main near-term risk. Chewy is betting on its Vet Care clinics, which are tracking toward about 60 sites with roughly $290 million of steady state revenue. Each site generates about $3.5 million in clinic revenue plus $0.8 million in attached Chewy.com sales. Projections point to revenue of $15.8 billion and earnings of $577.9 million by 2029, up from $273.7 million now. The most bullish analysts model $16.4 billion and $682.5 million, citing AI and automation.